Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, July 13, 2022
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
[ Wed, Jul 13th 2022
] - WOPRAI
Jayson Bedford Maintained (ANGO) at Strong Buy with Decreased Target to $27 on, Jul 13th, 2022
Jayson Bedford of Raymond James, Maintained "AngioDynamics, Inc." (ANGO) at Strong Buy with Decreased Target from $32 to $27 on, Jul 13th, 2022.
Jayson, nor any peers, have made any analyst calls on ANGO in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30